HIGHLIGHTS
- who: Cancer Metastasis and collaborators from the Melanie Swan Memorial Translational Centre, Faculty of Sci-Tech, University of Canberra, Bruce ACT, Australia have published the paper: SETDB-1: A Potential Epigenetic Regulator in Breast, in the Journal: (JOURNAL)
- what: Exactly how histone modifications reprogram gene_expression during metastasis is poorly understood.
- future: To address the enormous potential of SETDB1 targeting in breast cancer combination studies combining SETDB1 drugs either alone or in combination with other classes of epigenetic drugs such as LSD1 inhibitors either alone or with immunotherapy or chemotherapy drugs are urgently required . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.